FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38079911000001105: Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Mar 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1189321000001111 Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1189341000001118 Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Siponimod true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Siponimod 250microgram tablets true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Mayzent true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Siponimod false Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Siponimod fumaric acid true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 12 tablet Has AMP True Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has AMP True Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start